chartexchange

60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome

GlobeNewswire Inc. | Oct 28, 2026 8:30 AM EDT

60 Degrees Pharma partners with USM to study castanospermine in nonclinical alpha-gal syndrome models and explore botanical approval pathways.

Read original article